AI assistant
Medicus Pharma Ltd. — Director's Dealing 2025
May 21, 2025
34562_dirs_2025-05-21_029c0474-71ea-4b18-ab7d-c46bffcd2102.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-05-20
Reporting Person: VELOCITY FUND PARTNERS, LP (10% Owner)
Reporting Person: Melani Kenneth R. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-20 | Medicus Pharma LTD | S | 75000 | $7.7192 | Disposed | 3248741 | Indirect |
Footnotes
F1: The common shares were sold by Velocity Fund Partners, LP pursuant to an open market sale of 75,000 common shares on May 20, 2025 at a net price per common share of $7.7192.
F2: Represents 2,839,330 common shares held by Velocity Fund Partners, LP an entity controlled by Dr. Kenneth R. Melani and 409,411 common shares held directly by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership of common shares held by Velocity Fund Partners, LP, except to the extent of his pecuniary interest therein.